EWA
SION

EverSource Wealth Advisors’s Sionna Therapeutics SION Stock Holding History

EverSource Wealth Advisors’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880 Sell
20
-3
-13% -$120 ﹤0.01% 4007
2026
Q1 		$922 Buy
23
+3
+15% +$114 ﹤0.01% 3882
2025
Q4 		$823 Hold
20
– – ﹤0.01% 3760
2025
Q3 		$588 Buy
+20
New +$435 ﹤0.01% 3912

Other funds holding SION

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EverSource Wealth Advisors's SION Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Sionna Therapeutics (SION) stake by 13% in Q2 2026, selling an estimated $120 and leaving 20 shares worth $880. The position accounts for ﹤0.01% of the portfolio, ranked #4007.

EverSource Wealth Advisors first reported a position in SION in Q3 2025 and has held it in 4 quarters since. The position peaked at $922 in Q1 2026. 17 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • EverSource Wealth Advisors held 20 shares of Sionna Therapeutics worth $880 as of Q2 2026.
  • EverSource Wealth Advisors sold 3 Sionna Therapeutics shares in Q2 2026, an estimated $120.
  • Sionna Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4007 holding.
  • EverSource Wealth Advisors first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • EverSource Wealth Advisors's Sionna Therapeutics position peaked at $922 in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.